Menu
Back to User profile » Dr Valentina Buda
Papers published by Dr Valentina Buda:
Factors Influencing Adherence to Treatment and Quality of Life for a Group of Patients with Essential Hypertension in Romania
Suciu L, Suciu M, Voicu M, Mureșan R, Pârv FV, Buda V, Cristescu C
Patient Preference and Adherence 2021, 15:483-491
Published Date: 26 February 2021
Potentially Inappropriate Prescriptions in Ambulatory Elderly Patients Living in Rural Areas of Romania Using STOPP/START (Version 2) Criteria
Buda V, Prelipcean A, Andor M, Dehelean L, Dalleur O, Buda S, Spatar L, Mabda MC, Suciu M, Danciu C, Tudor A, Petrescu L, Cristescu C
Clinical Interventions in Aging 2020, 15:407-417
Published Date: 19 March 2020
The Predictive Value of Endothelial Inflammatory Markers in the Onset of Schizophrenia
Radu G, Luca C, Petrescu L, Bordejevic DA, Tomescu MC, Andor M, Cîtu I, Mavrea A, Buda V, Tomescu C, Borcan F, Dehelean L
Neuropsychiatric Disease and Treatment 2020, 16:545-555
Published Date: 24 February 2020
Thrombospondin-1 Serum Levels In Hypertensive Patients With Endothelial Dysfunction After One Year Of Treatment With Perindopril
Buda V, Andor M, Cristescu C, Tomescu MC, Muntean DM, Bâibâță DE, Bordejevic DA, Danciu C, Dalleur O, Coricovac D, Crainiceanu Z, Tudor A, Ledeti I, Petrescu L
Drug Design, Development and Therapy 2019, 13:3515-3526
Published Date: 8 October 2019
Evaluation of essential oil obtained from Mentha×piperita L. against multidrug-resistant strains
Muntean D, Licker M, Alexa E, Popescu I, Jianu C, Buda V, Dehelean CA, Ghiulai R, Horhat F, Horhat D, Danciu C
Infection and Drug Resistance 2019, 12:2905-2914
Published Date: 13 September 2019
Decreased sEng plasma levels in hypertensive patients with endothelial dysfunction under chronic treatment with Perindopril
Buda V, Andor M, Baibata DE, Cozlac R, Radu G, Coricovac D, Danciu C, Ledeti I, Cheveresan A, Nica C, Tuduce P, Tomescu MC
Drug Design, Development and Therapy 2019, 13:1915-1925
Published Date: 4 June 2019
A novel approach to cardiovascular disturbances in patients with schizophrenia spectrum disorders treated with long-acting injectable medication
Andor M, Dehelean L, Romosan AM, Buda V, Radu G, Caruntu F, Bordejevic A, Manea MM, Papava I, Bredicean CA, Romosan RS, Tomescu M
Neuropsychiatric Disease and Treatment 2019, 15:349-355
Published Date: 25 January 2019